ATS 2024 Final Program

Click on the session title to view the speakers

26

SUNDAY • MAYs 19

9:51 Prognostic Value of the Multicomponent Improvement (MCI) Endpoint in Patients With Pulmonary Arterial Hypertension (PAH) Treated With Sotatercept 10:03 Effect on Exercise Capacity and Long-Term Safety and Tolerability of Macitentan and Tadalafil as a Single-tablet Combination in Patients With Pulmonary Arterial Hypertension From the A DUE Open-label Interim Analysis 10:15 Initial Therapy in Pulmonary Arterial Hypertension and Cardiovascular Comorbidities: Monotherapy or Dual Combination? 10:27 Platelet-derived Growth Factor-BB (PDGF-BB) Antagonist Monoclonal Antibody as a Therapy for Pulmonary Arterial Hypertension 10:39 Early Home Rehabilitation Improves Activity and Quality After Acute Pulmonary Embolism 10:51 Metabolomic Signatures of Pulmonary Hypertension Associated With Interstitial Lung Disease: A Post-hoc Analysis of the INCREASE Study 11:03 Synthetic External Controls in Pulmonary Arterial Hypertension (PAH) Using Individual Participant Clinical Trial Data A15 PEDIATRIC ASTHMA - CLINICAL AND TRANSLATIONAL RESEARCH 9:15 a.m. - 11:15 a.m. San Diego Convention Center Room 2 (Upper Level) Oral Presentations: 9:15 Childhood Respiratory Outcomes Using Different Racial-ethnic Reference Equations for Spirometry 9:27 Association of Maternal Diet With the Maternal Gut Microbiome and Childhood Asthma 9:39 Exposure to Violence and Airway Epithelial Transcriptomic Profiles in Puerto Rican Youth 9:51 EHR-based Survival Analysis to Examine the Impact of the COVID-19 Pandemic on Severe Asthma Outcomes in Pediatrics BASIC • BEHAVIORAL • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

10:03 Association Between Hemoglobin A1c and Asthma Outcomes Among Children With Asthma 10:15 Ethnic Variation in Asthma Prevalence Across Childhood in the Asian American and Pacific Islander Population 10:27 Untargeted Metabolomic Profiling Identifies Potential Disease-specific Biomarkers in Urban Children With Obesity-related Asthma 10:39 Elevated Neutrophilic Responses in Infants Admitted for Bronchiolitis and Subsequent Lung Function 10:51 Metformin Use Is Associated With Reduced Acute Asthma Outcomes in Pediatric Population Featured Speaker Presentation: 11:03 Drivers of Asthma Outcomes: Looking Inside and Outside of the Lungs A16 NTMWITH A SIDE OF BRONCHIECTASIS 9:15 a.m. - 11:15 a.m. Marriott Marquis San Diego Marina Pacific Ballroom 24-26 (Ground Floor, North Tower) Oral Presentations: 9:15 Changes in Blood Immune Cell Transcriptomes Associate With Disease Severity, Infection, and Inflammation in Bronchiectasis Patients: Data From the EMBARC-BRIDGE Study 9:27 Sputum Microbiota Composition and Metabolome in Adults With COPD-Bronchiectasis Association: A Prospective Cohort Study 9:39 Change in Patient Reported Respiratory Symptoms in a Randomized, Double-blind, Trial of Amikacin Liposome Inhalation Suspension in Adults With Newly Diagnosed or Recurrent Mycobacterium Avium Complex Lung Disease: The ARISE Study 9:51 Microbiologic Outcomes From a Randomized, Double-blind Trial of Amikacin Liposome Inhalation Suspension in Adults With Newly Diagnosed or Recurrent Mycobacterium Avium Complex Lung Disease: The ARISE Study BASIC • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

ATS 2024 Conference Program • San Diego, CA